Moderna (NASDAQ:MRNA) announced that its late-stage trial for the mRNA-1647 vaccine, aimed at preventing cytomegalovirus infection, did not achieve its primary objective. The stock is down 3.9% after ...
Whether infection of cells by individual virions occurs randomly or if there is some form (s) of competition or cooperativity between individual virions remains largely unknown for most virus-cell ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback